Ovalife Met Tablet is a combination oral medication formulated to support metabolic and reproductive health, particularly in individuals with insulin resistance and polycystic ovary syndrome (PCOS). Each tablet contains Myo-Inositol (550 mg) and D-Chiro Inositol (13.8 mg), which are naturally occurring stereoisomers known to improve insulin sensitivity and promote hormonal balance. The inclusion of Metformin (500 mg), a well-established biguanide antihyperglycemic agent, aids in reducing hepatic glucose production and enhancing peripheral glucose uptake, thereby improving glycemic control. Additionally, the tablet is supplemented with L-Methyl Folate Calcium (0.5 mg), the bioactive form of folate essential for DNA synthesis and homocysteine metabolism, supporting cardiovascular and reproductive health. Methylcobalamin (750 mcg), the active form of vitamin B12, is included to prevent deficiency commonly associated with long-term metformin use and to support neurological function. Ovalife Met Tablet is indicated for patients requiring integrated management of insulin resistance, metabolic dysfunction, and micronutrient supplementation, contributing to improved ovulatory function and metabolic parameters. It should be used under medical supervision, with monitoring of blood glucose levels and vitamin B12 status to optimize therapeutic outcomes and minimize potential adverse effects.